2nd Quarter - Report

BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$900,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2014 $900,000 Replaced
2nd Quarter - Amendment Jul 31, 2014 $900,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H R 3309 Improving the Patent System to promote American Competitiveness and Innovation

LobbyistCovered position, as disclosed
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3309 (113th)

Budget/Appropriations BUD

Report language for Labor HHS Annual Appropriations BillHR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure. Medicare Part B Drug Reimbursement. H.R. 8 American Taxpayer Relief Act of 2012 -- working to mitigate the impact to kidney patients of the payment reductions required by the Act. HR 3306: Telehealth Enhancement Act of 2013.

LobbyistCovered position, as disclosed
MARK COIN —
JACK MANIKO —
KELLI MILLS LESTER —
JED PERRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8 (113th), H.R. 3306 (113th)

Taxation/Internal Revenue Code TAX

HR4213 -The tax Extenders Act of 2009; HR5297; The Small Business Jobs and Credit Act and HR 4853: The tax relief, unemployment Insurance Reauthorization and job Creation Act of 2010, as they related to the R&D tax credit ; Device Tax Legislation.HR 3630, Middle Class Tax Relief and Job Creation Act (this is the payroll tax relief extension bill) S. 1813, MAP-21 Act (the Senate highway bill with pension relief) HR 4196 and S.2240, extension of bonus depreciation S.2240/HR 4196, to extend bonus depreciation; and S. 2237, the Small Business Jobs and Tax Relief Act, as it relates to bonus depreciation. S. 1813/HR 4348, MAP-21, as it relates to pension funding relief. Issues related to the R&D tax credit, the taxation of U.S. multinational corporations and corporate tax reform. S. 3521, The Family and Business Tax Cut Certainty Act of 2012, HR 8, the American Taxpayer Relief Act. H.Con.Res. 25 S.Con. Res. Budget Resolutions S.886, S. 1013, H.R.845, H.R. 2024 Intellectual Property

LobbyistCovered position, as disclosed
JACK MANIKO —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8 (113th), H.R. 3630 (113th), H.R. 4213 (113th), S. 3521 (113th), H.R. 845 (113th), H.R. 4853 (113th), H.R. 4348 (113th), H.Con.Res. 25 (113th), S. 1013 (113th), H.R. 2024 (113th), H.R. 4196 (113th), S. 2240 (113th), S. 2237 (113th), H.R. 5297 (113th), S. 1813 (113th), S. 886 (113th)

Health Issues HCR

340B Drug Discount Program; FDA Regulatory Environment. Raise awareness with legislators about the benefits of home dialysis. Disease registry for Mutifocal Motor Neuropathy at NIH. Orphan Drug Act; BiosimilarsRaise Awareness with legislators about survey and certification issues as it relates to home dialysis. Compounding : Traceability reforms HR. 3204. Drug Quality & Security Act

LobbyistCovered position, as disclosed
MARK COIN —
SARAH CREVISTON —
JACK MANIKO —
KELLI MILLS LESTER —
JED PERRY —
JOSEPH V SCHWAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th)

Medicare/Medicaid MMM

Legislation to cut Medicare Part B Drug Reimbursement, Medicare Part B DME Competitive Bidding Program. Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. Pull through on Medicare demonstration to provide nursing services and supplies associated with home infusion of IVIG for patients with PIDD.

LobbyistCovered position, as disclosed
MARK COIN —
JACK MANIKO —
KELLI MILLS LESTER —
JED PERRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.